Biogen Patents – Key Insights and Stats

Biogen has a total of 9624 patents globally, out of which 4119 have been granted. Of these 9624 patents, more than 38% patents are active. United States of America is where Biogen has filed the maximum number of patents, followed by Europe and Japan. Parallelly, USA seems to be the main focused R&D center and also is the origin country of Biogen.

Biogen was founded in 1978 by Phillip Allen Sharp, Charles Weissmann, Walter Gilbert and Kenneth Murray. Biogen develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis. As of June 2022, Biogen has a market cap of $29.38 Billion.

Read about some of the most popular patents of Biogen which have been covered by us in this article and also you can find Biogen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Biogen patent portfolio.

How many patents does the Founder and CEO of Biogen have?

The Founder Phillip Allen Sharp has 157, Charles Weissmann has 90, Walter Gilbert has 54 and Kenneth Murray has 105 patents and the CEO Michel Vounatsos have 0 patents.

How many patents does Biogen have?

Biogen has a total of 9624 patents globally. These patents belong to 1264 unique patent families. Out of 9624 patents, 3701 patents are active.

How Many Patents did Biogen File Every Year?

Biogen Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBiogen Applications FiledBiogen Patents Granted
2011369172
2012392217
2013570223
2014386219
2015407246
2016252225
2017320236
2018272243
2019358242
2020246212
2021149221
20221657

How many Biogen patents are Alive/Dead?

Worldwide Patents

Biogen Patents Portfolio

How Many Patents did Biogen File in Different Countries?

Biogen Worldwide Patents

Countries in which Biogen Filed Patents

CountryPatents
United States Of America1306
Europe788
Japan719
Australia499
Hong Kong (S.A.R.)491
Canada374
China371
Korea (South)303
Germany287
Israel258
New Zealand226
Singapore213
India206
Spain202
Denmark199
Mexico181
Brazil179
Poland152
Portugal132
Slovenia119
Eurasia113
Austria106
South Africa99
Norway94
Hungary89
Taiwan77
Serbia76
Cyprus69
Argentina69
Malaysia67
Indonesia62
Philippines57
Chile56
Croatia56
Iceland52
Czech Republic48
Lithuania47
Albania46
Slovakia45
Estonia44
United Kingdom39
Georgia38
Russia38
Turkey38
Ukraine35
Bulgaria34
Viet Nam19
Uruguay18
Montenegro16
Colombia12
Peru11
Costa Rica10
Yugoslavia/Serbia and Montenegro10
Jordan10
Romania9
Finland9
Luxembourg7
Belarus5
Former Yugoslav Republic of Macedonia5
San Marino5
Saudi Arabia5
Ecuador4
Africa4
Netherlands4
Brunei3
Uzbekistan2
Nicaragua2
Tajikistan2
Ireland1
Italy1
Tunisia1
Honduras1
Morocco1
Gulf Cooperation Council1
Greece1
Dominican Republic1
United Arab Emirates1
Botswana1

Where are Research Centers of Biogen Patents Located?

Research Centers of Biogen Patents

10 Best Biogen Patents

US20030003097A1 is the most popular patent in the Biogen portfolio. It has received 510 citations so far from companies like Xencor Inc, Macrogenics Inc and Janssen Biotech Inc.

Below is the list of 10 most cited patents of Biogen:

Publication NumberCitation Count
US20030003097A1510
US6455043B1472
WO2002079255A1443
US6399061B1373
US6682734B1358
US20050163782A1332
US20020009444A1301
US20070148164A1288
US6602503B1263
US20020006404A1256

Which Companies are using Biogen Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Biogen patent portfolio are Immunomedics, Roche Holding and Amgen.

List of the top forward citing Companies –

CompanyNumber of Patents
Immunomedics14
Roche Holding Ag11
Amgen10
Genentech10
Novartis8
Chugai Seiyaku Kabushiki Kaisha7
Bristol-Myers Squibb6
Regeneron Pharmaceuticals Inc6
Teva Pharmaceutical Industries6
Xencor6

Count of 102 and 103 Type Rejections based on Biogen Patents

Top Biogen Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20090252729A115
US20070148164A114
US20160259913A111
US7422899B210
US20090258420A19
US20020193569A18
US20050053598A18
US7820161B17
US20030157641A17
US6896885B27
US20050163782A17
US7951918B27
US20060182740A17
US6455043B17
US20060204503A16

What Percentage of Biogen US Patent Applications were Granted?

Biogen (Excluding its subsidiaries) has filed 70 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 52 have been granted leading to a grant rate of 78.7%.

Below are the key stats of Biogen patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Biogen?

Law FirmTotal ApplicationsSuccess Rate
Pillsbury Winthrop Shaw Pittman Llp14100.00%
Sidley Austin Llp1190.91%
Arnold & Porter Kaye Scholer Llp1050.00%
Pillsbury Winthrop Shaw Pittman Llp5100.00%
Sterne Kessler Goldstein & Fox Pllc580.00%
Foley Hoag Llp W Bii & Bgh466.67%
Birch Stewart Kolasch & Birch Llp3100.00%
Biogen2100.00%
Genentech Inc250.00%
Lando & Anastasi Llp2100.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Biogen key innovation segments?

What Technologies are Covered by Biogen?

The chart below distributes patents filed by Biogen in different countries on the basis of the technology protected in patents. It also represents the markets where Biogen thinks it’s important to protect particular technology inventions.

R&D Focus: How has Biogen search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Biogen?

Updated on September 17, 2022

Was this article helpful?

Leave a Comment